There are 2789 resources available
1365TiP - A phase I/II, open-label study of BBT-176, a triple mutation targeting EGFR TKI, in patients with NSCLC who progressed after prior EGFR TKI therapy
Presenter: Sun Min Lim
Session: ePoster Display
1366TiP - Tepotinib + osimertinib for EGFR-mutant NSCLC with resistance to first-line osimertinib due to MET amplification (METamp): INSIGHT 2
Presenter: Yi-Long Wu
Session: ePoster Display
1367TiP - IMPRINTER: An open label, multi-center, dose escalation/expansion, phase I study of IMU-201 (PD1-Vaxx), a B-cell immunotherapy, in adults with non-small cell lung cancer
Presenter: Rita Laeufle
Session: ePoster Display
1368TiP - EPROPA: The European program for routine testing of patients with advanced lung cancer
Presenter: Francesco Passiglia
Session: ePoster Display
1371TiP - Radiotherapy combined with apatinib and PD-1 inhibitors in patients with brain metastases from non-small cell lung cancer: A single-arm exploratory clinical study
Presenter: Hongwei li
Session: ePoster Display
1375P - SHR-1701, a novel bifunctional anti-PD-L1/TGF-βRII agent, for pretreated recurrent/refractory (r/r) gastric cancer (GC): Data from a first-in-human phase I study
Presenter: Dan Liu
Session: ePoster Display